Innovating Works

NIMR

MpoxVax AFRIVAC: Expanding a prospective clinical trial examining the immune response of participants receiving Modi... The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and ov...
2024-10-03 - 2027-03-31 | Financiado
ODIN-MPox: Implementing wastewater and environmental surveillance for Mpox in Sub Saharan Africa NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox, a re-emerging viral zoonotic disease, has recently posed significant public health challenges in sub-Saharan Africa, particularly in t...
2024-08-07 - 2026-07-31 | Financiado
RER-CTO: Reinforce the Ethical and Regulatory Ecosystem for the Transformation of Clinical Trials Oversight i... Why RER-CTO?: The conduct of clinical trials requires competent ethics committee and regulatory authorities that can review clinical trial a...
2024-06-11 - 2027-06-30 | Financiado
SEMA ReACT: SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote... NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Annually, almost 500,000 children under 5 years die from malaria in Africa. Timely access to effective antimalarial therapies is life saving...
2023-03-07 - 2027-03-31 | Financiado
TherVacB: THERVACB A THERAPEUTIC VACCINE TO CURE HEPATITIS B NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un H2020: H2020-SC1-BHC-2018-2020 Experts in virology, immunology and clinical hepatitis B patient care with an excellent research and translational track record in hepatitis...
2019-12-06 - 2024-12-31 | Financiado
INTE-AFRICA: Integrating and decentralising diabetes and hypertension services in Africa NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un H2020: H2020-SC1-BHC-2018-2020 We will integrate and scale up services for diabetes and hypertension in clinics in Tanzania and Uganda, either as standalone or integrated...
2018-12-04 - 2023-06-30 | Financiado
IPV_Tanzania: Investigating the predictors of intimate partner violence A mixed method longitudinal study in Tanz... NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un H2020: ERC-2016-STG This study proposes a major advance in research on intimate partner violence (IPV), a prominent public health and human rights issue. Worldw...
2017-07-10 - 2023-05-31 | Financiado
EHVA: European HIV Vaccine Alliance EHVA a EU platform for the discovery and evaluation of novel prophy... NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un H2020: H2020-PHC-2014-2015 Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. T...
2015-12-17 - 2023-12-31 | Financiado
STOPPAM: Strategies TO Prevent Pregnancy Associated Malaria NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un FP7: The Partners propose to conduct a cohort study in pregnant women and their newborns to quantify the effects of Pregnancy-Associated Malaria...
Financiado
INTHEC: Health Education and Community Integration Evidence based Strategies to increase equity integratio... NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un FP7: Objectives: The research aims to improve the delivery of reproductive health (RH) services in Tanzania and Niger by generating new evidence...
Financiado
MASCOT: Multilateral Association for Studying health inequalities and enhancing north south and south south... NATIONAL INSTITUTE FOR MEDICAL RESEARCH participó en un FP7: Inequalities and vulnerable groups’ health, as well as the slow advances to achieve the health- related Millennium Development Goals, are co...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.